Study S002123

Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07849348
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 266
Start: 2026-09
Primary completion: 2027-02
Lead sponsor: Peking University People's Hospital
Conditions: Obesity; Chronic Kidney Disease; Albuminuria
Interventions: DRUG:Finerenone; DRUG:Finerenone Placebo; DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Change From Baseline in Urinary Albumin-to-Creatinine Ratio (UACR) at Week 24 [Baseline to Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.